Maria Giulia Zampino

Istituti di Ricovero e Cura a Carattere Scientifico — Italy

Medicine · Health Sciences

33h-index4.2kcitations176works6.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(82), Gastric Cancer Management and Outcomes(42), Cancer Genomics and Diagnostics(32), Colorectal and Anal Carcinomas(31), Colorectal Cancer Surgical Treatments(30)

Publications173 total

Randomized phase 3 study of intermittent or continuous Panitumumab plus FOLFIRI for first-line treatment of patients with unresectable left-sided RAS/BRAF wild-type metastatic colorectal cancer: the IMPROVE-2 trial
2025Open Access
Total neoadjuvant therapy followed by non-operative management or surgery in stage II–III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial
The Lancet Oncology·2025· 5 cited
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy
ESMO Open·2025Open Access
Integrating tissue and liquid biopsy comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer: Findings from the CAPRI-2 GOIM study
European Journal of Cancer·2025· 4 cited
415P Comprehensive nutritional assessment in patients with locally advanced gastroesophageal adenocarcinoma in the perioperative setting: A sub-analysis of a prospective observational study
Annals of Oncology·2025
Author response for "Clinical/pathological features and survival outcomes of extra-pulmonary neuroendocrine carcinomas: A retrospective single-center series"
2025
3381 hypofractionated proton therapy for primary intrahepatic cancers: time for a pivotal role? a systematic review and meta-analysis
Radiotherapy and Oncology·2025
Molecular tumour board in gastrointestinal cancers
ESMO Open·2025· 1 citedOpen Access
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial
ESMO Open·2025· 11 citedOpen Access
Treatment of Oligometastatic BRAFV600E Mutant Colorectal Cancer: Learning From a Clinical Case
Clinical Colorectal Cancer·2025
BRAFV600E mutant metastatic colorectal cancer: Current advances in personalized treatment and future perspectives
Cancer Treatment Reviews·2025· 8 cited
The use of liquid biopsy comprehensive genomic profiling to identify the molecular landscape of patients with metastatic colorectal cancer who are candidates for anti-EGFR rechallange therapy: Findings from the CAVE-2 GOIM trial.
Journal of Clinical Oncology·2025· 1 cited
Author response for "Clinical/pathological features and survival outcomes of extra-pulmonary neuroendocrine carcinomas: A retrospective single-center series"
2024
Investigating the Pathogenicity of Uncommon KRAS Mutations and Their Association with Clinicopathologic Characteristics in Patients with Colorectal Cancer
Journal of Molecular Diagnostics·2024· 2 cited
Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers
ESMO Open·2024· 8 citedOpen Access
114P Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAFV600E wild type metastatic colorectal cancer in the CAPRI 2-GOIM trial
ESMO Open·2024· 3 citedOpen Access
509O Total neoadjuvant treatment (TNT) with non-operative management (NOM) for proficient mismatch repair locally advanced rectal cancer (pMMR LARC): First results of NO-CUT trial
Annals of Oncology·2024· 10 citedOpen Access
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial
Annals of Oncology·2024· 17 citedOpen Access
Unfavorable carcinoma of unknown primary with a gastrointestinal profile: a retrospective study
ESMO Open·2024· 1 citedOpen Access
26P Response in patient-derived models recapitulates circulating tumor DNA clearance of matched colon cancer patients after adjuvant treatment in the PEGASUS trial
Annals of Oncology·2024Open Access
page 1 of 9Next →

Frequent Co-authors

Nicola Fazio(17), Sara Lonardi(13), Paola Simona Ravenda(10), Roberto Labianca(9), Elena Magni(9), Alberto Zaniboni(8), Mario Scartozzi(8), Evaristo Maiello(8), Gerardo Rosati(7), Monica Ronzoni(7), Vittorina Zagonel(7), Filippo de Braud(7), Franco Orsi(6), Maria Banzi(6), Paolo Marchetti(6), Filippo Pietrantonio(6), Franco Nolè(6), Salvatore Siena(5), Roberto Biffi(5), Antonio Chiappa(5)